ADORA2A rs5751876: What Your Genotype Means
The rs5751876 variant is a genetic polymorphism located within the ADORA2A gene, which encodes the adenosine A2A receptor. Research suggests this variant may influence how individuals respond to caffeine, particularly regarding anxiety levels, sleep quality, and physiological arousal.
What each genotype means
Lower caffeine sensitivity
Individuals with this genotype are often categorized as non-responders or having lower sensitivity to the anxiogenic effects of caffeine. Research suggests these individuals may have higher habitual caffeine consumption, potentially requiring higher doses to achieve the same pharmacological or ergogenic effects compared to T-allele carriers. Please discuss your caffeine intake and any health concerns with your clinician or pharmacist.
This is a common genotype in many populations, though exact frequencies vary by ancestry.
Intermediate caffeine sensitivity
This genotype represents an intermediate state between the C/C and T/T profiles regarding caffeine sensitivity. You may experience moderate responses to caffeine in terms of anxiety or sleep modulation, depending on your total daily intake. Please discuss your caffeine intake and any health concerns with your clinician or pharmacist.
This heterozygous genotype is frequently observed in diverse populations.
Higher caffeine sensitivity
This genotype is associated with increased sensitivity to the effects of caffeine, including a higher susceptibility to caffeine-induced anxiety and potential impacts on sleep quality. Some studies indicate that individuals with this genotype may experience more pronounced physiological responses to moderate caffeine consumption. Please discuss your caffeine intake and any health concerns with your clinician or pharmacist.
The T allele is less common than the C allele in many populations, making this homozygous genotype relatively less frequent.
Understanding the rs5751876 Variant
The rs5751876 variant is a single-nucleotide polymorphism (SNP) found within the ADORA2A gene. In genetic databases, this variant is often described as a synonymous change, meaning it does not alter the amino acid sequence of the resulting protein. However, its significance lies in its location and its tight linkage to other functional variants within the same gene. Because it is inherited alongside these other markers, it serves as a useful proxy for studying how variations in the adenosine A2A receptor influence human behavior and physiology. Scientists track this specific SNP to better understand the biological mechanisms that cause people to react differently to stimulants like caffeine. While it is a well-studied marker in the context of neuropsychiatric research, it is important to remember that genetic variants rarely act in isolation; they often interact with other genes and environmental factors to shape individual traits.
The Role of the ADORA2A Gene
The ADORA2A gene provides instructions for creating the adenosine A2A receptor, a protein found primarily in the brain, particularly in areas involved in movement, motivation, and emotional regulation. Adenosine is a chemical messenger that typically promotes sleep and suppresses arousal by binding to these receptors. When caffeine is consumed, it acts as an antagonist, blocking adenosine from binding to its receptors. By preventing the 'braking' effect of adenosine, caffeine promotes wakefulness and alertness. Because the ADORA2A receptor is a primary target for caffeine, variations in the gene that encodes it can theoretically alter how sensitive a person is to the effects of caffeine. Research into this gene is essential for understanding the complex interplay between our internal chemistry and external substances that modulate our nervous system, such as coffee, tea, and other caffeinated beverages.
Research Associations and Evidence
Scientific literature has explored the association between rs5751876 and various traits, most notably caffeine-induced anxiety and sleep disturbances. Some studies have observed that individuals carrying the T-allele may experience higher levels of anxiety or physiological arousal following caffeine consumption compared to those who are homozygous for the C-allele. Additionally, research has investigated whether this variant influences EEG alpha activity, a measure of brain arousal, during sleep or wakefulness. While these findings are intriguing, the evidence remains limited. Many studies have been conducted on relatively small sample sizes, and results have sometimes been mixed or difficult to replicate across different populations. Furthermore, while some research suggests a link to panic disorder susceptibility, these associations are not definitive. It is crucial to view these findings as statistical observations in research cohorts rather than diagnostic indicators for any individual.
Population Frequency
The rs5751876 variant is relatively common in human populations. Data indicates that the minor allele frequency typically ranges between 0.35 and 0.45 in cosmopolitan populations. This means that a significant portion of the general population carries at least one copy of the less common allele, making it a widely distributed genetic marker rather than a rare mutation.
Interpreting Your Genetic Information
If you have information about your rs5751876 genotype, it is important to interpret it with caution. Genetic research provides insights into population-level trends, but it cannot predict how a specific individual will react to caffeine or any other substance. Factors such as your overall health, daily habits, tolerance levels, and other genetic markers play a much larger role in your personal experience than any single SNP. This information is for educational purposes and should not be used to make medical decisions or to diagnose conditions like anxiety or sleep disorders. If you have concerns about your sleep, anxiety levels, or how caffeine affects your health, the best course of action is to consult with a healthcare professional or a registered dietitian. They can provide personalized advice based on your clinical history rather than relying on genetic data alone.
How common is this variant?
The minor allele frequency for rs5751876 is approximately 0.35-0.45 in cosmopolitan populations, indicating that the variant is widely distributed across diverse ancestral groups.
Frequently asked questions
Does the rs5751876 variant mean I have a caffeine allergy?
No. This variant is associated with variations in how sensitive you might be to the effects of caffeine, such as anxiety or sleep disruption, but it is not a marker for a caffeine allergy.
Can I use this genetic information to diagnose anxiety?
Absolutely not. Genetic variants like rs5751876 are studied for their statistical associations with traits in large groups and cannot be used to diagnose any medical or psychiatric condition in an individual.
Should I change my coffee intake based on my genotype?
You should not make changes to your diet or health habits based solely on this genetic information. If you are concerned about how caffeine affects your health, discuss your habits and symptoms with a doctor or nutritionist.
Is the evidence for this variant strong?
The evidence is considered limited. While several studies have identified associations, the results have been mixed, and larger, more diverse studies are needed to confirm these findings.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5751876?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADORA2A
The T allele of this variant is associated with increased caffeine-induced anxiety and sleep disturbances.
This variant is associated with individual differences in caffeine sensitivity and sleep patterns.
Functional regulatory variant modulating adenosine A2A receptor transcription, sleep EEG slow-wave power, and caffeine-induced sleep disruption.
An adenosine A2A receptor variant that alters sensitivity to caffeine-induced anxiety, panic symptoms, and sleep architecture disruption.
Key adenosine A2A receptor regulatory variant influencing caffeine-induced sleep disturbance, slow-wave sleep reduction, and anxiety-related insomnia.